| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.02 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.093 | 0.02 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.02 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | -0.07 | 0.02 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.02 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.02 |